News

Professor Walid Khaled from CSCI and co-leader Dr Laura Greaves from Newcastle have received UKRI funding for research on age-related biological changes in model organisms as part of a national collaboration.UKRI funding of £3 million is awarded today (12 February) to support a new research cluster as part of the MRC National Mouse Genetics Network…

This Tuesday (6 February), our Cambridge Stem Cell Institute Technology & Innovation Forum (SCI-TIF) and Institute researchers participated in our first SCI-TIF event of 2024, highlighting collaboration between industry and academia. The event started with an introduction from CSCI Director Bertie Gottgens, then introduced flash talks from three of…

On World Cancer Day yesterday (4 February), Blood Cancer UK and the American charity Leukemia & Lymphoma Society (LLS) announced the start of a transformative five-year, £4 million research project in Cambridge, spearheaded by CSCI’s Professor George Vassiliou. The project aims to establish a clinical platform to identify individuals at high risk o…

Large-scale genetic analysis has helped researchers uncover the interplay between cancer-driving genetic mutations and inherited genetic variants in a rare type of blood cancer. Researchers from the Wellcome-MRC Cambridge Stem Cell Institute, Wellcome Sanger Institute, the University of Cambridge, and collaborators combined various comprehensive da…

A new collaborative paper from the Göttgens, Kranc and O’Carroll groups reports the first model of homeostatic in vivo tissue dynamics that is anchored in single cell genomics data in the Cell Stem Cell publication out last week (5 January). In time series measurements extending over 9 months, the Kranc Group (Institute of Cancer Research, London) …

On Friday 8 December, CSCI PI Kostantinos Tzelepis presented his research at the Annual American Society of Hematology (ASH) Meeting in San Diego, USA. This presentation focused on the pre-clinical development and characterisation of the first-in-class METTL1 RNA Methyltransferase inhibitor, a totally novel anticancer therapeutic for various aggres…

On Friday 1 December, CSCI celebrated our second annual Christmas Market at the Jeffrey Cheah Biomedical Centre. Partnering with our neighbours at Cancer Research UK Cambridge Institute and Cambridge Biomedical Campus, and with volunteers from The Milner Therapeutics Institute and Cambridge Institute of Therapeutic Immunology & Infectious Disease, …

It was announced today that Dr Alecia-Jane Twigger has been awarded a UK Research and Innovation (UKRI) Future Leaders Fellowship. These Fellowships are awarded by UKRI to support universities and businesses in developing their most talented early career researchers and innovators. Dr Twigger, a Research Associate in Professor Walid Khaled’s lab at…

Last week, the journal Leukemia announced CSCI PI Dr Konstantinos Tzelepis as one of three Emerging Leaders in Leukemia. The Nature Publishing Group journal’s Emerging Leaders collection selects rising talent in the field of haematology, providing a spotlight so they can share their work with others. Kostas and his group at CSCI are currently focus…

It was announced today (18 October) that Dr Sarah Teichmann and her group will join the Cambridge Stem Cell Institute (CSCI)Sarah will be moving from the Wellcome Sanger Institute, where she has been heading the Cellular Genetics programme. Sarah is a highly distinguished computational biologist, and co-lead of the international Human Cell Atlas in…

Dr Thorsten Boroviak joins us this month (from 1 October) as a Principal Investigator researching primate embryogenesis. Dr Boroviak joins us from the Department of Physiology, Development and Neuroscience at University of Cambridge. CSCI Director Bertie Göttgens comments on Dr Boroviak's appointment:"I am very happy to welcome Thorsten Boroviak to…

Professor Sanjay Sinha and his team have just been announced (28 September) as one of the four world-class teams to receive a share of £18 million to pursue transformational bioscience research programmes.The four teams will tackle bold challenges at the frontiers of bioscience, combining world-class ideas, people and transformative technologies wi…

Neuroblastoma is responsible for 15% of cancer deaths in children. Research out today from the Philpott Lab offers hope to these children, who could in future be given treatments with fewer side-effects than those associated with the current chemotherapy.The approach involves the use of a ‘differentiation therapy’, a type of treatment that does not…

Today (6 September)the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) welcomed Indian entrepreneur Ashok Soota from SKAN Research Trust (SKAN) to Cambridge to mark an upcoming partnership between the two organisations that will bring cutting edge expertise in stem cell research to India. CSCI Director Professor Bertie Göttgens said of the partne…

In March, Cancer Grand Challenges announced nine new challenges, with 178 interdisciplinary, world-class global teams submitting bold ideas to take them on. Today (5 September 2023), 12 teams have been shortlisted to further their research and compete for up to $25m in funding.CSCI PI Maria Alcolea has been announced as one of the Cambridge researc…